пятница, 24 февраля 2017 г.

Merck drug prevents serious infection after marrow transplant: study

Merck drug prevents serious infection after marrow transplant: study


An experimental Merck & Co drug succeeded in preventing clinically serious cytomegalovirus following bone marrow transplant and was associated with a lower death rate compared with placebo in a late state study, the company said. Merck said it will apply for U.S. and European approval of the antiviral drug letermovir this year.



from Biotech News